{"id":"W2034693832","doi":"10.1016/j.clbc.2011.04.001","title":"Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Bevacizumab; Capecitabine; Breast cancer; Mucositis; Internal medicine; Oncology; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Regimen; Cancer; Surgery; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007453062,0.0002748644,0.000864072,0.00006795205,0.0001738572,0.00001101079,0.0001634055,0.0001627748,0.0004767361],"category_scores_gemma":[0.00004222274,0.0001722509,0.0001877816,0.0002811104,0.001092478,0.0001212866,0.0000972596,0.0003526394,5.959868e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001734757,"about_ca_system_score_gemma":0.0008214139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00340944,"about_ca_topic_score_gemma":0.0006764634,"domain_scores_codex":[0.9975283,0.0002288382,0.0008151613,0.0005900492,0.0004291769,0.000408548],"domain_scores_gemma":[0.9980739,0.0003526376,0.000470618,0.0003289361,0.0005205286,0.000253389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4133575,0.005006976,0.01195748,0.0001639383,0.0009156137,0.000008825024,0.0006673578,0.000001254045,0.01780233,0.000146836,0.001909668,0.5480622],"study_design_scores_gemma":[0.8406132,0.04773963,0.07356015,0.001304728,0.001636679,0.0002169299,0.0003480546,0.0002366739,0.01509291,0.0003228206,0.01836634,0.000561871],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987146,0.003932501,0.00005063067,0.003860267,0.0007211363,0.003470873,0.000676499,0.00001802625,0.0001240344],"genre_scores_gemma":[0.9904295,0.007393476,0.00009921895,0.0003225962,0.0004191598,0.0008819782,0.00004206807,0.0000396284,0.0003723666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5475003,"threshold_uncertainty_score":0.7024188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07746102873287435,"score_gpt":0.4472544011442907,"score_spread":0.3697933724114163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}